| Commentary on resveratrol and hormesis: resveratrol--a hormetic marvel in waiting? | |
| | |
MedLine Citation:
|
PMID: 21115564 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hormesis is a phenomenon in which adaptive responses to low doses of otherwise-harmful factors (also called mild stressors) make cells and organisms more robust. In their review, Calabrese et al. provide evidence for resveratrol acting hormetically in different types of human cell lines. The effects of resveratrol represent a 'two-edged sword' in that it has contrasting effects at low and high doses in healthy and cancerogenous cells. What demarcates a low and a high dose needs to be clarified. Concentrations tested in cell cultures, moreover, may not be relevant to whole organisms. And data from animal models need not apply to humans. Co-morbidities should also be considered. More research is needed to understand the action of resveratrol on all cell types and conditions, and the optimum therapeutic concentration that applies to each of these. Future research needs to determine the dynamics of the effects of resveratrol in different subcellular compartments and the interactions of these. In addition, the interactions between resveratrol, environmental factors, other compounds and medications, diseases and the genetic background of the individual will need to be appreciated in order to gain a complete understanding of the hormetic response of resveratrol. |
| | |
Authors:
|
Francine Z Marques; Brian J Morris |
Related Documents
:
|
18983864 - Limitations and relative utility of screening assays to assess engineered nanoparticle ... 7694134 - Further evaluation of a modified micronucleus assay with v79 cells for detection of ane... 19426924 - Evaluation of cytotoxicity of mta employing various additives. 17181164 - 9-benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, ... 7878224 - Development of early cell lineages in marsupial embryos: an overview. 21848654 - Glucose and ethylene signalling pathways converge to regulate trans-differentiation of ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Human & experimental toxicology Volume: 29 ISSN: 1477-0903 ISO Abbreviation: Hum Exp Toxicol Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-30 Completed Date: 2011-03-11 Revised Date: 2012-01-26 |
Medline Journal Info:
|
Nlm Unique ID: 9004560 Medline TA: Hum Exp Toxicol Country: England |
Other Details:
|
Languages: eng Pagination: 1026-8 Citation Subset: IM |
Affiliation:
|
Basic and Clinical Genomics Laboratory, School of Medical Sciences and Bosch Institute, Anderson Stuart Building, University of Sydney, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Biological Availability Biomedical Research* / methods, standards Dose-Response Relationship, Drug* Humans Nonprescription Drugs / standards Solubility Stilbenes / administration & dosage*, adverse effects, pharmacokinetics, pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Nonprescription Drugs; 0/Stilbenes; 501-36-0/resveratrol |
| Comments/Corrections | |
Comment In:
|
Hum Exp Toxicol. 2010 Dec;29(12):980-1015
[PMID:
21115559
]
Hum Exp Toxicol. 2011 Dec;30(12):2027-30 [PMID: 21558146 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Commentary on 'resveratrol commonly displays hormesis: occurrence and biomedical significance'.
Next Document: Commentary on 'resveratrol commonly displays hormesis: occurrence and biomedical significance'.